A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation

A novel coronavirus from patients with pneumonia in China, 2019

Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969

Virological assessment of hospitalized patients with COVID-2019

Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661

Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma

Shen, C., Wang, Z., Zhao, F., Yang, Y., Li, J., Yuan, J., Wang, F., Li, D., Yang, M., Xing, L., et al. (2020) · JAMA · doi:10.1001/jama.2020.4783 · Cited by 2,298

A serological assay to detect SARS-CoV-2 seroconversion in humans

Amanat, F., Stadlbauer, D., Strohmeier, S., Nguyen, T. H. O., Chromikova, V., McMahon, M., Jiang, K., Arunkumar, G. A., Jurczyszak, D., Polanco, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0913-5 · Cited by 1,769

Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients

Okba, N. M. A., Müller, M. A., Li, W., Wang, C., GeurtsvanKessel, C. H., Corman, V. M., Lamers, M. M., Sikkema, R. S., de Bruin, E., Chandler, F. D., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200841 · Cited by 1,614

Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report

Mulligan, M. J., Lyke, K. E., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Neuzil, K., Raabe, V., Bailey, R., Swanson, K. A., et al. (2020) · doi:10.1101/2020.06.30.20142570 · Cited by 1,569

A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity

Huang, A. T., Garcia-Carreras, B., Hitchings, M. D. T., Yang, B., Katzelnick, L. C., Rattigan, S. M., Borgert, B. A., Moreno, C. A., Solomon, B. D., Trimmer-Smith, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18450-4 · Cited by 1,026

A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity

(2020) · Nature Communications · doi:10.1101/2020.04.14.20065771 · Cited by 1,019

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2

Nie, J., Li, Q., Wu, J., Zhao, C., Hao, H., Liu, H., Zhang, L., Nie, L., Qin, H., Wang, M., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1743767 · Cited by 711

From crisis to innovation in point-of-care testing: Lessons from the COVID-19 pandemic and future directions

Lu, X., Du, J., You, M., Chen, L., Xu, F., & Chen, F. (2024) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2024.118131 · Cited by 26

Rapid test to assess the escape of SARS-CoV-2 variants of concern

Heggestad, J. T., Britton, R. J., Kinnamon, D., Wall, S. A., Joh, D. Y., Hucknall, A., Olson, L. B., Anderson, J. G., Mazur, A., Wolfe, C. R., et al. (2021) · Science Advances · doi:10.1126/sciadv.abl7682 · Cited by 25

Strategies for Immunomonitoring after Vaccination and during Infection

Adam, L., Rosenbaum, P., Bonduelle, O., & Combadière, B. (2021) · Vaccines · doi:10.3390/vaccines9040365 · Cited by 25

SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing

Rathe, J. A., Hemann, E. A., Eggenberger, J., Li, Z., Knoll, M. L., Stokes, C., Hsiang, T.-Y., Netland, J., Takehara, K. K., Pepper, M., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa797 · Cited by 22

An Inter‐Supplementary Biohybrid System Based on Natural Killer Cells for the Combinational Immunotherapy and Virotherapy of Cancer

Ding, L. J., Gao, Q., Xu, Z., Cai, L., Chen, S., Zhang, X., Cao, P., & Chen, G. (2021) · Advanced Science · doi:10.1002/advs.202103470 · Cited by 23

Using alt text to make science Twitter more accessible for people with visual impairments

Chiarella, D., Yarbrough, J., & Jackson, C. A.-L. (2020) · Nature Communications · doi:10.1038/s41467-020-19640-w · Cited by 24

Towards Quantitative and Standardized Serological and Neutralization Assays for COVID-19

Tian, L., Elsheikh, E. B., Patrone, P. N., Kearsley, A. J., Gaigalas, A. K., Inwood, S., Lin‐Gibson, S., Esposito, D., & Wang, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052723 · Cited by 23

Recent Developments in SARS-CoV-2 Neutralizing Antibody Detection Methods

Ndzouboukou, J. B., Zhang, Y., & Fan, X. (2021) · Current Medical Science · doi:10.1007/s11596-021-2470-7 · Cited by 23

Ultrarapid and ultrasensitive detection of SARS‐CoV‐2 antibodies in COVID‐19 patients via a 3D‐printed nanomaterial‐based biosensing platform

Ali, M. A., Zhang, F., Hu, C., Yuan, B., Jahan, S., Kitsios, G. D., Morris, A., Gao, S., & Panat, R. P. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28075 · Cited by 24

Colloidal gold immunochromatographic assay (GICA) is an effective screening method for identifying detectable anti-SARS-CoV-2 neutralizing antibodies

Li, X., Yin, Y., Pang, L., Xu, S., Lu, F., Xu, D., & Shen, T. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.05.080 · Cited by 23

More Than Just Gene Therapy Vectors: Lentiviral Vector Pseudotypes for Serological Investigation

Toon, K., Bentley, E. M., & Mattiuzzo, G. (2021) · Viruses · doi:10.3390/v13020217 · Cited by 23

Optimization and evaluation of a live virus SARS-CoV-2 neutralization assay

Frische, A., Brooks, P. T., Gybel‐Brask, M., Sækmose, S. G., Jensen, B. A., Mikkelsen, S., Bruun, M. T., Boding, L., Polacek, C., Jørgensen, C. S., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272298 · Cited by 22

Antibody titers against the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 induced by BNT162b2 vaccination measured using automated chemiluminescent enzyme immunoassay

Kato, H., Miyakawa, K., Ohtake, N., Go, H., Yamaoka, Y., Yajima, S., Shimada, T., Goto, A., Nakajima, H., & Ryo, A. (2021) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2021.11.021 · Cited by 22

Long-term decay of anti-RBD IgG titers after BNT162b2 vaccination is not mirrored by loss of neutralizing bioactivity against SARS-CoV-2

Malipiero, G., D’Agaro, P., Segat, L., Moratto, A., & Villalta, D. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.11.023 · Cited by 22

Method for the Rapid Detection of SARS-CoV-2-Neutralizing Antibodies Using a Nanogel-Based Surface Plasmon Resonance Biosensor

Lee, S., Yim, B., Park, J., Kim, N.-G., Kim, B., Park, Y., Yoon, Y. K., & Kim, J. (2023) · ACS Applied Polymer Materials · doi:10.1021/acsapm.2c02187 · Cited by 21

Research progress in methods for detecting neutralizing antibodies against SARS-CoV-2

Chen, C., Liang, J., Hu, H., Li, X., Wang, L., & Wang, Z. (2023) · Analytical Biochemistry · doi:10.1016/j.ab.2023.115199 · Cited by 22

Biochemical composition, transmission and diagnosis of SARS-CoV-2

Ahirwar, R., Gandhi, S., Komal, K., Dhaniya, G., Tripathi, P. P., Shingatgeri, V., Kumar, K., Sharma, J. G., & Kumar, S. (2021) · Bioscience Reports · doi:10.1042/bsr20211238 · Cited by 21

Outcomes of vaccinations against respiratory diseases in patients with end-stage renal disease undergoing hemodialysis: A systematic review and meta-analysis

Puspitasari, M., Sattwika, P. D., Rahari, D. S., Wijaya, W., Hidayat, A. R. P., Kertia, N., Purwanto, B., & Thobari, J. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281160 · Cited by 24

Importance, Applications and Features of Assays Measuring SARS-CoV-2 Neutralizing Antibodies

Gattinger, P., Ohradanova‐Repic, A., & Valenta, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065352 · Cited by 24

Aptamer‐based strategies against SARS‐CoV‐2 viruses

Huang, Y., Chen, X., Zhang, J., Tian, W., Liu, S., Tam, R. C., Yang, C. J., & Song, Y. (2023) · BMEMat · doi:10.1002/bmm2.12024 · Cited by 19

SARS-CoV-2 Neutralization Assays Used in Clinical Trials: A Narrative Review

Sun, Y., Huang, W., Xiang, H., & Nie, J. (2024) · Vaccines · doi:10.3390/vaccines12050554 · Cited by 20

PRAK-03202: A triple antigen virus-like particle vaccine candidate against SARS CoV-2

Mazumder, S., Rastogi, R., Undale, A., Arora, K., Arora, N. M., Pratim, B., Kumar, D., Joseph, A., Mali, B., Arya, V. B., et al. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08124 · Cited by 18

A Systematic Review and Meta-Analysis Comparing the Diagnostic Accuracy Tests of COVID-19

Vilca-Alosilla, J. J., Candia-Puma, M. A., Coronel-Monje, K., Goyzueta-Mamani, L. D., Galdino, A. S., Machado‐de‐Ávila, R. A., Giunchetti, R. C., Coelho, E. A. F., & Chávez‐Fumagalli, M. Á. (2023) · Diagnostics · doi:10.3390/diagnostics13091549 · Cited by 18

Serological antibody testing in the COVID-19 pandemic: their molecular basis and applications

Jiang, J.-C., & Zhang, Y. (2020) · Biochemical Society Transactions · doi:10.1042/bst20200744 · Cited by 19

Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants

Anichini, G., Terrosi, C., Savellini, G. G., Gandolfo, C., Franchi, F., & Cusi, M. G. (2021) · Vaccines · doi:10.3390/vaccines9050517 · Cited by 18

BNT162b vaccines are immunogenic and protect non-human primates against SARS-CoV-2Preprint

Vogel, A. B., Kanevsky, I., Che, Y., Swanson, K. A., Muik, A., Vormehr, M., Kranz, L. M., Walzer, K. C., Hein, S., Güler, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.11.421008 · Cited by 18

Therapeutic Role of Neutralizing Antibody for the Treatment against SARS-CoV-2 and Its Emerging Variants: A Clinical and Pre-Clinical Perspective

Bhattacharya, M., Chatterjee, S., Mallik, B., Sharma, A. R., & Chakraborty, C. (2022) · Vaccines · doi:10.3390/vaccines10101612 · Cited by 16

Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages

Xia, H., Yeung, J., Kalveram, B., Bills, C. J., Chen, J. Y.-C., Kurhade, C., Zou, J., Widen, S. G., Mann, B. R., Kondor, R. J. G., et al. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2161422 · Cited by 17

Convalescent Plasma against COVID-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious Diseases

Thijssen, M., Devos, T., Ejtahed, H., Amini‐Bavil‐Olyaee, S., Pourfathollah, A. A., & Pourkarim, M. R. (2020) · Microorganisms · doi:10.3390/microorganisms8111733 · Cited by 17

The next‐generation coronavirus diagnostic techniques with particular emphasis on the SARS‐CoV‐2

Hemida, M. G. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26926 · Cited by 16

Quantum optical immunoassay: upconversion nanoparticle-based neutralizing assay for COVID-19

Rajil, N., Esmaeili, S., Neuman, B. W., Nessler, R., Wu, H., Yi, Z., Brick, R. W., Sokolov, A. V., Hemmer, P., & Scully, M. O. (2022) · Scientific Reports · doi:10.1038/s41598-021-03978-2 · Cited by 17

Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine–A Study Protocol

Chopra, A., Chavan, P., Tillu, G. S., Saluja, M., Borse, S., Sarmukaddam, S. B., Chaudhuri, S., Rao, B., Yadav, B., Srikanth, N., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.761655 · Cited by 16

Liposome-based high-throughput and point-of-care assays toward the quick, simple, and sensitive detection of neutralizing antibodies against SARS-CoV-2 in patient sera

Streif, S., Neckermann, P., Spitzenberg, C., Weiß, K. T., Hoecherl, K., Kulikowski, K., Hahner, S., Nölting, C., Einhauser, S., Peterhoff, D., et al. (2023) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-023-04548-3 · Cited by 17

High-Throughput Neutralization and Serology Assays Reveal Correlated but Highly Variable Humoral Immune Responses in a Large Population of Individuals Infected with SARS-CoV-2 in the US between March and August 2020

Zhang, S., Ma, P., Orzechowski, M., Lemmer, A., Rzasa, K. M., Bagnall, J., Barkho, S., Chen, M., He, L. L., Neitupski, R., et al. (2023) · mBio · doi:10.1128/mbio.03523-22 · Cited by 16

Engineered Ultra-High Affinity Synthetic Antibodies for SARS-CoV-2 Neutralization and Detection

Ślężak, T., & Kossiakoff, A. A. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.166956 · Cited by 16

Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans

Yu, S., Chen, K., Fang, L., Mao, H., Lou, X., Li, C., & Zhang, Y. (2021) · Vaccines · doi:10.3390/vaccines9060588 · Cited by 17

Severity of COVID-19 Infection Using Chest Computed Tomography Severity Score Index Among Vaccinated and Unvaccinated COVID-19-Positive Healthcare Workers: An Analytical Cross-Sectional Study

Naik, B. R., Kumar, S. A., Rachegowda, N., Ullas, L. Y., Revanth, R., & Aluru, N. R. V. S. (2022) · Cureus · doi:10.7759/cureus.22087 · Cited by 16

The Coronavirus Standards Working Group’s roadmap for improved population testing

Mercer, T. R., Almond, N. M., Chain, P., Crone, M. A., Deshpande, A., Eveleigh, D., Freemont, P. S., Fuchs, S., Garlick, R. K., Huggett, J. F., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01538-1 · Cited by 18

A modified porous silicon microparticle potentiates protective systemic and mucosal immunity for SARS-CoV-2 subunit vaccine

Adam, A., Shi, Q., Wang, B., Zou, J., Mai, J., Osman, S. R., Wu, W., Xie, X., Aguilar, P. V., Bao, X., et al. (2021) · Translational research · doi:10.1016/j.trsl.2022.06.004 · Cited by 19

Virofree, an Herbal Medicine-Based Formula, Interrupts the Viral Infection of Delta and Omicron Variants of SARS-CoV-2

Doan, L. H., Chu, L.-W., Huang, Z.-Y., Nguyen, A. T., Lee, C., Huang, C., Chang, Y.-F., Hsieh, W.-Y., Nguyen, T. T. H., Lin, C., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.905197 · Cited by 15

Progress in SARS-CoV-2, diagnostic and clinical treatment of COVID-19

Li, Y., Lu, S.-M., Wang, J.-L., Yao, H., & Liang, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33179 · Cited by 15

Evaluation of a SARS-CoV-2 lateral flow assay using the plaque reduction neutralization test

Xie, X., Nielsen, M. C., Muruato, A. E., Fontes-Garfias, C. R., & Ren, P. (2020) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115248 · Cited by 15

Making sense of spike D614G in SARS-CoV-2 transmission

Shi, A. C., & Xie, X. (2021) · Science China Life Sciences · doi:10.1007/s11427-020-1893-9 · Cited by 15

Practical guidance for clinical laboratories for SARS-CoV-2 serology testing

Charlton, C. L., Kanji, J. N., Tran, V., Kus, J. V., Gubbay, J. B., Osiowy, C., Robinson, J. L., Sekirov, I., DREBOT, M. A., Hatchette, T. F., et al. (2021) · Canada Communicable Disease Report · doi:10.14745/ccdr.v47i04a01 · Cited by 14

Handheld Thermo-Photonic Device for Rapid, Low-Cost, and On-Site Detection and Quantification of Anti-SARS-CoV-2 Antibody

Thapa, D., Samadi, N., & Tabatabaei, N. (2021) · IEEE Sensors Journal · doi:10.1109/jsen.2021.3089016 · Cited by 15

The Role of Serology Testing in the Context of Immunization Policies for COVID-19 in Latin American Countries

Ferreira, C. D. S., Dantés, H. G., Bellei, N., López, E. L., Crespo, K. A. N., O’Ryan, M., & Villegas, J. (2021) · Viruses · doi:10.3390/v13122391 · Cited by 16

Correction: Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis

Peng, H. T., Rhind, S. G., & Beckett, A. (2021) · JMIR Public Health and Surveillance · doi:10.2196/31554 · Cited by 16

Neutralization of Omicron SARS-CoV-2 by 2 or 3 doses of BNT162b2 vaccinePreprint

Xia, H., Zou, J., Kurhade, C., Cai, H., Yang, Q., Cutler, M. W., Cooper, D., Muik, A., Jansen, K. U., Xie, X., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.21.476344 · Cited by 15

Aptamer-based diagnosis of various SARS-CoV2 strains isolated from clinical specimens

Moshref, Z. S., Jalali, T., Adriani, R. R., Soltati, E., & Gargari, S. L. M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16458 · Cited by 14

Overlaid Lateral Flow Immunoassay for the Simultaneous Detection of Two Variant-Specific SARS-CoV-2 Neutralizing Antibodies

Deenin, W., Khongchareonporn, N., Ruxrungtham, K., Ketloy, C., Hirankarn, N., Wangkanont, K., Rengpipat, S., Yakoh, A., & Chaiyo, S. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.3c05144 · Cited by 13

Recombinant Mycobacterium paragordonae Expressing SARS-CoV-2 Receptor-Binding Domain as a Vaccine Candidate Against SARS-CoV-2 Infections

Kim, B.-J., Jeong, H., Seo, H., Lee, M.-H., Shin, H. M., & Kim, B.-J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.712274 · Cited by 13

A Single-Round Infection Fluorescent SARS-CoV-2 Neutralization Test for COVID-19 Serological Testing at a Biosafety Level-2 Laboratory

Zou, J., Xia, H., Shi, P., Xie, X., & Ren, P. (2022) · Viruses · doi:10.3390/v14061211 · Cited by 12

A review post-vaccination SARS-CoV-2 serological test: Method and antibody titer response

Devi, M. J., Gaffar, S., & Hartati, Y. (2022) · Analytical Biochemistry · doi:10.1016/j.ab.2022.114902 · Cited by 12

Multiplexed Lab-on-a-Chip Bioassays for Testing Antibodies against SARS-CoV-2 and Its Variants in Multiple Individuals

Mou, L., Zhang, Y., Feng, Y., Hong, H., Xia, Y., & Jiang, X. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c04383 · Cited by 13

Bovine Serum Albumin-Protected Gold Nanoclusters for Sensing of SARS-CoV-2 Antibodies and Virus

Shen, Q., Hossain, F., Fang, C., Shu, T., Zhang, X., Law, J. L., Logan, M. R., Houghton, M., Tyrrell, D. L., Joyce, M., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c03705 · Cited by 12

Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies

Zhong, C., Xia, H., Adam, A., Wang, B., Hajnik, R. L., Liang, Y., Rafael, G. H., Zou, J., Wang, X., Sun, J., et al. (2021) · npj Vaccines · doi:10.1038/s41541-021-00405-5 · Cited by 13

Response to and outcomes of the Pfizer BNT162B2 vaccine in hemodialysis patients—A prospective observational study

Al‐Muhaiteeb, A., AlSahow, A., Alyousef, A., Alhelal, B. A., AlRajab, H., Bahbahani, Y., dewidar, N., & Fanous, G. N. M. (2022) · Hemodialysis International · doi:10.1111/hdi.13005 · Cited by 12

The arrival of SARS-CoV-2–neutralizing antibodies in a currently available commercial immunoglobulin

Miller, A. L., Rider, N. L., Pyles, R. B., Judy, B. M., Xie, X., Shi, P., & Ksiazek, T. G. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.03.026 · Cited by 12

An Overview of the Conventional and Novel Methods Employed for SARS-CoV-2 Neutralizing Antibody Measurement

Rocha, V. P. C., Quadros, H. C., Fernandes, A. M. S., Gonçalves, L. P., Badaró, R. J. D. S., Soares, M. B. P., & Machado, B. A. S. (2023) · Viruses · doi:10.3390/v15071504 · Cited by 13

Neutralizing Effect of Synthetic Peptides toward SARS-CoV-2

Souza, P. F. N., van Tilburg, M. F., Mesquita, F. P., Amaral, J. L., Lima, L. B., Montenegro, R. C., Lopes, F. E. S., Martins, R. X., Vieira, L., Farias, D. F., et al. (2022) · ACS Omega · doi:10.1021/acsomega.2c02203 · Cited by 12

Comparative analysis of replication and immune evasion among SARS-CoV-2 subvariants BA.2.86, JN.1, KP.2, and KP.3

Hu, Y., Zou, J., Nguyen, M., Chang, H. C., Yeung, J., Hao, H., Shi, P., Ren, P., & Xie, X. (2025) · mBio · doi:10.1128/mbio.03503-24 · Cited by 11

Identification of SARS-CoV-2 Neutralizing Antibody with Pseudotyped Virus-based Test on HEK-293T hACE2 Cells

Gillot, C., Favresse, J., Maloteau, V., Dogné, J.-M., & Douxfils, J. (2022) · BIO-PROTOCOL · doi:10.21769/bioprotoc.4377 · Cited by 9

A Novel and Secure Pseudovirus Reporter System Based Assay for Neutralizing and Enhancing Antibody Assay Against Marburg Virus

Bi, J., Wang, H., Pei, H., Han, Q., Feng, N., Wang, Q., Wang, X., Wang, Z., Wei, S., Ge, L., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.927122 · Cited by 11

Sandwich/competitive immuno-sensors on micro-interface for SARS-CoV-2 neutralizing antibodies

Lin, Q., Wu, J., Liu, L., Wu, W., Fang, X., & Kong, J. (2021) · Analytica Chimica Acta · doi:10.1016/j.aca.2021.339144 · Cited by 12

A runtime alterable epidemic model with genetic drift, waning immunity and vaccinations

Getz, W. M., Salter, R. M., Vissat, L. L., Koopman, J. S., & Simon, C. P. (2021) · Journal of The Royal Society Interface · doi:10.1098/rsif.2021.0648 · Cited by 12

Longitudinal waning of mRNA vaccine-induced neutralizing antibodies against SARS-CoV-2 detected by an LFIA rapid test

Wang, Q., Feng, L., Zhang, H., Gao, J., Mao, C., Landesman‐Bollag, E., Mostoslavsky, G., Lunderberg, J. M., Zheng, W., Hao, S., et al. (2022) · Antibody Therapeutics · doi:10.1093/abt/tbac004 · Cited by 11

Review on In Silico Methods, High-throughput Screening Techniques, and Cell Culture Based In Vitro Assays for SARS-CoV-2

Çetin, Y., Aydınlık, Ş., Güngör, A., Kan, T., Avşar, T., & Durdağı, S. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220627121416 · Cited by 11

CRISPR/Cas13a-assisted AMP generation for SARS-CoV-2 RNA detection using a personal glucose meter

Park, J., Han, H., Jeung, J. H., Jang, H., Park, C., & Ahn, J. K. (2022) · Biosensors and Bioelectronics X · doi:10.1016/j.biosx.2022.100283 · Cited by 10

Advanced microscopy technologies enable rapid response to SARS‐CoV ‐2 pandemic

Cortese, M., & Laketa, V. (2021) · Cellular Microbiology · doi:10.1111/cmi.13319 · Cited by 9

SARS-CoV-2 Antibody Neutralization Assay Platforms Based on Epitopes Sources: Live Virus, Pseudovirus, and Recombinant S Glycoprotein RBD

Septisetyani, E. P., Prasetyaningrum, P. W., Anam, K., & Santoso, A. (2021) · Immune Network · doi:10.4110/in.2021.21.e39 · Cited by 11

Comparative Analysis of Circulating Levels of SARS-CoV-2 Antibodies and Inflammatory Mediators in Healthcare Workers and COVID-19 Patients

de‐Oliveira‐Pinto, L. M., Solórzano, V. F., Martins, M. D. L., Fernandes-Santos, C., Damasco, P. H., Siqueira, M. M., Dias, H. G., Pauvolid‐Corrêa, A., Damasco, P. V., & de Azeredo, E. L. (2022) · Viruses · doi:10.3390/v14030455 · Cited by 9

Analysis and comparison of anti-RBD neutralizing antibodies from AZD-1222, Sputnik V, Sinopharm and Covaxin vaccines and its relationship with gender among health care workers

Zare, H., Rezapour, H., Fereidouni, A., Nikpour, S., Mahmoudzadeh, S., Royce, S. G., & Fereidouni, M. (2022) · Immunity & Ageing · doi:10.1186/s12979-022-00303-x · Cited by 10

Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging

Schaefer, E. J., Comite, F., Dulipsingh, L., Lang, M., Jimison, J., Grajower, M. M., Lebowitz, N. E., Geller, A. S., Diffenderfer, M. R., He, L., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252818 · Cited by 10

Neutralizing activity to SARS‐CoV ‐2 of convalescent and control plasma used in a randomized controlled trial

Freedenberg, A. T., Pan, C., Diehl, W. E., Romeiser, J. L., Hwang, G., Leiton, C. V., Muecksch, F., Shroyer, K. R., & Bennett‐Guerrero, E. (2021) · Transfusion · doi:10.1111/trf.16283 · Cited by 9

Sampling and analytical techniques for COVID-19

Purohit, S., Rao, P. K., & Rawtani, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90272-4.00008-7 · Cited by 9

BNT162b2-elicited neutralization of Delta plus, Lambda, Mu, B.1.1.519, and Theta SARS-CoV-2 variants

Liu, J., Liu, Y., Xia, H., Zou, J., Weaver, S. C., Swanson, K. A., Cai, H., Cutler, M. W., Cooper, D., Muik, A., et al. (2022) · npj Vaccines · doi:10.1038/s41541-022-00462-4 · Cited by 9

Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections

Zou, J., Xie, X., Liu, M., Shi, P., & Ren, P. (2022) · mBio · doi:10.1128/mbio.01996-22 · Cited by 8

An ELISA Platform for the Quantitative Analysis of SARS-CoV-2 RBD-neutralizing Antibodies As an Alternative to Monitoring of the Virus-Neutralizing Activity

Kostin, N. N., Bobik, T. V., Skryabin, G. A., Simonova, M. A., Knorre, V. D., Abrikosova, V. A., Mokrushina, Y. A., Smirnov, I. V., Aleshenko, N. L., Kruglova, N. A., et al. (2022) · Acta Naturae · doi:10.32607/actanaturae.11776 · Cited by 10

Sustainable Resumption of Cardiac Catheterization Laboratory Procedures, and the Importance of Testing, During Endemic COVID-19

Zaman, M., Tiong, D., Saw, J., Zaman, S. J., & Daniels, M. J. (2021) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-021-00901-w · Cited by 9

Development of an Indirect ELISA for the Detection of SARS-CoV-2 Antibodies in Cats

Bold, D., Román‐Sosa, G., Gaudreault, N. N., Batsukh, Z., Pogranichniy, R. M., & Richt, J. A. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.864884 · Cited by 11

A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and Heavily Spike-Mutated SARS-CoV-2 Variants of Concern in the Syrian Hamster ModelPreprint

Prakash, S., Dhanushkodi, N. R., Singer, M., Quadiri, A., Zayou, L., Vahed, H., Coulon, P.-G. A., Ibraim, I. C., Tafoya, C., Hitchcock, L., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.14.580225 · Cited by 10

Navigating the Landscape of B Cell Mediated Immunity and Antibody Monitoring in SARS-CoV-2 Vaccine Efficacy: Tools, Strategies and Clinical Trial Insights

O’Reilly, S. R., Byrne, J., Feeney, E. R., Mallon, P. W. G., & Gautier, V. (2024) · Vaccines · doi:10.3390/vaccines12101089 · Cited by 8

Advances in Surrogate Neutralization Tests for High-Throughput Screening and the Point-of-Care

Streif, S., & Baeumner, A. J. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c00666 · Cited by 8

Correlation of sample‐to‐cut‐off ratio of anti‐SARS‐CoV‐2 IgG antibody chemiluminescent assay with neutralization activity: a prospective multi‐centric study in India

Tiwari, A. K., Negi, G., Jaiswal, R. M., Aggarwal, G., Yadav, N., Kumar, V., & Kulathu, K. (2021) · ISBT Science Series · doi:10.1111/voxs.12644 · Cited by 8

Persistence of the neutralizing antibody response after SARS-CoV-2 infection

Shim, S., Kim, J., Jung, S., Jung, Y., Woo, H., Yang, J., Kim, K.-C., & Lee, J.-Y. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.12.012 · Cited by 8

Detecting SARS-CoV-2 neutralizing immunity: highlighting the potential of split nanoluciferase technology

Jeremiah, S. S., Miyakawa, K., & Ryo, A. (2022) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjac023 · Cited by 8

Serum peptidome profiles immune response of COVID-19 Vaccine administration

Zhang, W., Li, D., Xu, B., Xu, L., Lyu, Q., Liu, X., Li, Z., Zhang, J., Sun, W., Ma, Q., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.956369 · Cited by 8

Immunological Studies to Understand Hybrid/Recombinant Variants of SARS-CoV-2

Chavda, V. P., Mishra, T., & Vuppu, S. (2022) · Vaccines · doi:10.3390/vaccines11010045 · Cited by 8

An Evaluation of a SARS-CoV-2 Pseudovirus Neutralization Test and A Comparison to a SARS-CoV-2 Surrogate Virus Neutralization Test in a COVID-19 Long-Term Follow-Up Cohort

Gillot, C., Favresse, J., David, C., Maloteau, V., Dogné, J., & Douxfils, J. (2024) · Microbiology Research · doi:10.3390/microbiolres15010028 · Cited by 9

Microsampling: A role to play in Covid‐19 diagnosis, surveillance, treatment and clinical trials

Rajadhyaksha, M., & Londhe, V. Y. (2021) · Drug Testing and Analysis · doi:10.1002/dta.3107 · Cited by 8

Amino acids 484 and 494 of SARS-CoV-2 spike are hotspots of immune evasion affecting antibody but not ACE2 bindingPreprint

Alenquer, M., Ferreira, F., Lousa, D., Valério, M., Medina-Lopes, M., Bergman, M., Gonçalves, J., Demengeot, J., Leite, R. B., Lilue, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.22.441007 · Cited by 8

A Spike-Based mRNA Vaccine Encapsulated in Phospholipid 1,2-Dioleoyl-sn-Glycero-3-PhosphoEthanolamine Containing Lipid Nanoparticles Induced Potent B- and T-Cell Responses Associated with Protection Against SARS-CoV-2 Infection and COVID-19-like Symptoms in Hamsters

Quadiri, A., Prakash, S., Zayou, L., Dhanushkodi, N. R., Chilukuri, A., Ryan, G., Wang, K., Vahed, H., Chentoufi, A. A., & BenMohamed, L. (2025) · Vaccines · doi:10.3390/vaccines13010047 · Cited by 7

SARS-CoV-2 Seroprevalence Among Whole Blood Donors During First Wave of Covid-19 Pandemic in India

Chunchu, S. R., Ravula, U., Gente, V. K., Bacchu, S., Rao, S. P. R., & Mooli, S. (2022) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-021-01512-y · Cited by 7

Performance analysis among multiple fully automated anti-SARS-CoV-2 antibody measurement reagents: A potential indicator for the correlation of protection in the antibody titer

Kobayashi, R., Suzuki, E., Murai, R., Tanaka, M., Fujiya, Y., & Takahashi, S. (2022) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2022.05.016 · Cited by 8

Rapid and Quantitative In Vitro Evaluation of SARS-CoV-2 Neutralizing Antibodies and Nanobodies

Wu, W., Tan, X., Zupancic, J. M., Schardt, J. S., Desai, A. A., Smith, M. D., Zhang, J., Xie, L., Oo, M. K. K., Tessier, P. M., et al. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c00062 · Cited by 7

Distinct neutralizing kinetics and magnitudes elicited by different SARS-CoV-2 variant spikesPreprint

Liu, Y., Liu, J., Zou, J., Ren, P., Weaver, S. C., Xie, X., & Shi, P. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.02.458740 · Cited by 6

A validated and standardized pseudotyped microneutralization assay as a safe and powerful tool to measure LASSA virus neutralising antibodies for vaccine development and comparison

Antonelli, R., Forconi, V., Molesti, E., Semplici, C., Piu, P., Altamura, M., Dapporto, F., Temperton, N. J., Montomoli, E., & Manenti, A. (2024) · F1000Research · doi:10.12688/f1000research.149578.2 · Cited by 6

Infecting kidney organoids with a cDNA reporter clone of SARS-CoV-2

Chung, H., Bui-Marinos, M. P., Rahmani, W. M., Corcoran, J. A., & Chun, J. (2022) · STAR Protocols · doi:10.1016/j.xpro.2022.101617 · Cited by 5

The SARS-CoV-2 Antibodies, Their Diagnostic Utility, and Their Potential for Vaccine Development

Hajissa, K., Mussa, A., Karobari, M. I., Abbas, M. A., Ibrahim, I. K., Assiry, A. A., Iqbal, A., Alhumaid, S., Mutair, A. S. A., Rabaan, A. A., et al. (2022) · Vaccines · doi:10.3390/vaccines10081346 · Cited by 7

Performance and correlation of ten commercial immunoassays for the detection of SARS-CoV-2 antibodies

Lokida, D., Karyana, M., Kosasih, H., Mardian, Y., Sugiyono, R. I., Arlinda, D., Lukman, N., Salim, G., Butar-butar, D. P., Naysilla, A. M., et al. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12614 · Cited by 6

Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples

Bennett, R. S., Postnikova, E. N., Liang, J. Y., Gross, R., Mazur, S., Dixit, S., Lukin, V. V., Kocher, G., Yu, S., Georgia, S., et al. (2021) · Viruses · doi:10.3390/v13050893 · Cited by 29

Development of a SARS-CoV-2 monoclonal antibody panel and its applicability as a reagent in high-throughput fluorescence reduction neutralization and immunohistochemistry assaysPreprint

Coelho, G. M., Cataneo, A. H. D., Raboni, S. M., Nogueira, M. B., de Paula, C. B. V., Almeida, A. C., Rogerio, V. Z., Zanchin, N. I. T., de Noronha, L., Zanluca, C., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.29.542720

A flow cytometry‐based assay to measure neutralizing antibodies against SARS‐CoV ‐2 virus

Pscheidt, V. M., de Souza, P. O., Fazolo, T., Proença‐Módena, J. L., Simeoni, C. L., de Toledo-Teixeira, D. A., Brunetti, N. S., Bispo-dos-Santos, K., Júnior, L. R., & Bonorino, C. (2024) · Cytometry Part A · doi:10.1002/cyto.a.24838 · Cited by 1

Development of an anti‐SARS‐CoV‐2 monoclonal antibody panel and its applicability as a reagent in high‐throughput fluorescence reduction neutralization and immunohistochemistry assays

Coelho, G. M., Cataneo, A. H. D., Raboni, S. M., Nogueira, M. B., de Paula, C. B. V., Almeida, A. C., Rogerio, V. Z., Zanchin, N. I. T., de Noronha, L., Zanluca, C., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29111 · Cited by 3

A Novel Adaptive Platform for Rapid, Simple Flow-Based Antibody Detection Devices Predicts NAb Levels to SARS-CoV-2

Markmann, A., Bhowmik, D. R., Jiang, B., Vanna, U. P., Hoy, M. V., Wang, F., Hou, Y., Margolis, D., Baric, R. S., de Silva, A., et al. (2026) · Pathogens and Immunity · doi:10.20411/pai.v11i1.910